Cargando…
Looking at CER from the Pharmaceutical Industry Perspective
BACKGROUND: Comparative effectiveness research (CER) is increasing as an element of health care reform in the United States. By comparing drugs against other drugs or other therapies instead of just to placebo, CER has the potential to improve decisions about the appropriate treatment for patients....
Autor principal: | Dubois, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437711/ https://www.ncbi.nlm.nih.gov/pubmed/22578212 http://dx.doi.org/10.18553/jmcp.2012.18.s4-a.S09 |
Ejemplares similares
-
Looking at CER from Medicare’s Perspective
por: Mohr, Penny
Publicado: (2012) -
Looking at CER from the Managed Care Organization Perspective
por: Cannon, H. Eric
Publicado: (2012) -
Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011) -
Implementing CER: What Will It Take?
por: Biskupiak, Joseph E., et al.
Publicado: (2012) -
Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012)